RxSight, Inc. (RXST) stock
RXSTNasdaqOphthalmic GoodsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3074% below fair value
$5.38+0.10 (+1.89%)
Close on Nov 12, 2026Market cap $223.77MP/E –Yield –
RxSight enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
RxSight's enterprise value was $10.77M on Nov 11, 2026, against $241.65M a year earlier. Over the last 5 years it ranged from -$18.43M to $2.11B, with a median of $275.27M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $10.77M | -94.6% |
| 2025 | Dec 31, 2025 | $200.57M | -82.5% |
| 2024 | Dec 31, 2024 | $1.15B | -12.7% |
| 2023 | Dec 29, 2023 | $1.31B | +451.0% |
| 2022 | Dec 30, 2022 | $238.40M | +71.4% |
| 2021 | Dec 31, 2021 | $139.10M | – |
See a number that looks wrong?